nanoparticle vincristine (BIND Therapeutics)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namenanoparticle vincristine (BIND Therapeutics)
Drug Alias NameAccurin cytotoxics (BIND Therapeutics)molecularly-targeted Accurins (BIND Therapeutics)Accurin chemotherapeutics (BIND Therapeutics)vincristineBIND-510
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstate-specific antigen modulators
TargetsProstate-specific antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDNIB Unwind Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDNIB Unwind IncAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A